Evidence map›Paper›PMID 39694473›Full record

ArticlePsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2025

A case of severe ARIA with multiple infarctions and extensive microbleeds following lecanemab administration.

Akiko Yamazaki, Tetsuro Sekine, Shiro Takahashi, Koji Sohara, Masanori Sakamaki, Takehiko Nagao, Kazumi Kimura, Masahiro Mishina

Abstract readCase Reports
In one paragraph

Article in Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Regulatory, clinical, and post-marketing challenges of lecanemab for Alzheimer's disease: insights from real-world data.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akiko YamazakiDementia-Related Disease Medical Centre, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan.ORCID https://orcid.org/0009-0003-7254-4621
Tetsuro SekineDepartment of Radiology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan.
Shiro TakahashiDepartment of Neurology, Nippon Medical School, Tokyo, Japan.
Koji SoharaDepartment of Radiology, Nippon Medical School Hospital, Tokyo, Japan.
Masanori SakamakiDepartment of Neurology, Nippon Medical School, Tokyo, Japan.
Takehiko NagaoDepartment of Neurology, Nippon Medical School, Tokyo, Japan.
Kazumi KimuraDepartment of Neurology, Nippon Medical School, Tokyo, Japan.
Masahiro MishinaDementia-Related Disease Medical Centre, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan.ORCID https://orcid.org/0000-0002-8227-0930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amyloid‐related imaging abnormalitiesanti‐amyloid β antibodyinfarctionslecanemabmicrobleeds

Identifiers

PMID39694473
PMCPMC11655173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.